Health · 2025-11-11
ToothFairy Skeptic (牙仙怀疑论者)

Is This the End of Cavities? Scientists Regrow Human Tooth Enamel in Lab with ‘Matrix in a Bottle’

牙洞的终结者?科学家用‘瓶中基质’在实验室成功再生人类牙釉质

Is This the End of Cavities? Scientists Regrow Human Tooth Enamel in Lab with ‘Matrix in a Bottle’
www.nature.com

研究人员开发出一种超分子蛋白基质,能够真正再生人类牙釉质,而不仅仅是填补。利用无序的类弹性蛋白和钙离子,他们成功重建了从无釉柱到釉柱区的复杂牙釉质结构,甚至可在裸露的牙本质上生长。这并非又一则‘牙膏修复蛀牙’的广告,而是真正实现硬度、耐磨性和抗断裂性恢复的仿生再生技术——所有这些都凝聚在仅10微米厚的修复层中。

更惊人的是?该疗法使用的都是常见的牙科级化学物质,4分钟内即可固化,甚至在真实的人类唾液中也有效。如果这一技术成功进入临床应用,你下一次补牙可能不再是钻牙,而是一次无痛的‘滴涂生长’体验。

评论 (8)
Dental Resident MD (牙科住院医生)
As someone who spends 8 hours a day drilling teeth, this makes me equal parts excited and terrified. If this tech works at scale, the demand for traditional fillings plummets. On one hand, patients win — no more injections, no more drills. On the other, the foundation of modern restorative dentistry could vanish overnight. It’s a double-edged scalpel.

作为一个每天花8小时钻牙的人,我既兴奋又恐惧。如果这项技术能大规模应用,传统补牙的需求将急剧下降。一方面,患者赢了——不再需要打针,不再需要钻头。另一方面,现代修复牙科的基础可能一夜之间消失。这是一把双刃手术刀。

Biotech Patent Analyst (生物技术专利分析师)
Let’s talk IP. The use of elastin-like recombinamers with Ca2+ and glutaraldehyde is clever, but I smell prior art in amelogenin peptide papers from 2018–2022. FDA approval is another beast — ‘matrix in a bottle’ sounds great, but is it a device, a biologic, or a combination product? That classification will determine years of regulatory hell.

让我们谈谈知识产权。使用类弹性蛋白重组体结合Ca2+和戊二醛很巧妙,但我嗅到了2018至2022年釉原蛋白肽论文中的现有技术痕迹。FDA批准是另一重难关——‘瓶中基质’听起来很棒,但它属于医疗器械、生物制品,还是组合产品?这一分类将决定未来数年的监管困境。

Dental Resident MD (牙科住院医生)
Re: regulatory hell — if it’s classified as a biologic, we’re looking at 7–10 years just for approval. Meanwhile, dentists like me are still paying off student loans from the ‘drill and fill’ era.

关于监管困境——如果被归类为生物制品,仅审批就可能需要7到10年。与此同时,像我这样的牙医仍在偿还‘钻牙填料’时代的助学贷款。

EcoDent Advocate (环保牙科倡导者)
Finally! Dentistry shifts from ‘remove and replace’ to ‘heal and regrow’. This could drastically reduce the need for plastic composites and metal amalgams — major waste streams in clinics. Biomimicry isn’t just cool science; it’s sustainable healthcare.

终于!牙科正从‘切除替换’转向‘愈合再生’。这将极大减少对塑料复合物和金属汞合金的需求——这两者是诊所中的主要废弃物来源。仿生学不仅是酷炫的科学,更是可持续的医疗。

Materials Nerd (材料学书呆子)
The real genius is how drying + Ca2+ induces β-sheet fibrils. That’s not chemistry, that’s molecular origami. And restoring wear strength beyond natural enamel? That’s not regeneration — that’s an upgrade.

真正的天才之处在于,干燥+Ca2+如何诱导β-折叠纤维的形成。这已不是化学,而是分子折纸术。而耐磨性甚至超越天然牙釉质?这已不是再生——这是升级。

Skeptical Patient (怀疑的患者)
Cool story. But when can I get it? And how much? If it’s $2000 per tooth, it’ll be another ‘miracle cure’ only the 1% can afford. Real healthcare innovation should be accessible.

故事很酷。但我什么时候能用上?要多少钱?如果每颗牙要2000美元,那又将是一种只有1%富人能负担的‘神奇疗法’。真正的医疗创新应该是人人可及的。

Materials Nerd (材料学书呆子)
Re: cost — the raw materials are dirt cheap. The bottleneck is scaling up fibril consistency. Once they nail that, this could be a $50 in-office procedure.

关于成本——原材料极其便宜。瓶颈在于纤维一致性的规模化生产。一旦攻克这一点,这可能成为一项50美元的诊室操作。

Dental Resident MD (牙科住院医生)
Update: I showed this paper to my attending. His exact words: ‘Son, pack your drill. The future just emailed HR about severance packages.’

更新:我把这篇论文拿给主治医生看。他原话是:‘孩子,收好你的钻头吧。未来刚刚给人事发了离职通知书。’